Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct;10(10):647-86.

Hepatitis D Virus: A Call to Screening

Affiliations

Hepatitis D Virus: A Call to Screening

Joseph Ahn et al. Gastroenterol Hepatol (N Y). 2014 Oct.

Abstract

Hepatitis D virus causes an aggressive viral hepatitis with a virulent course of progression to cirrhosis and hepatic decompensation. It relies on hepatitis B coinfection for its pathogenesis and propagation. Hepatitis D virus had become the forgotten virus, with reduced public awareness, medical interest, and research support. Recently, there has been a resurgence of awareness and interest in hepatitis D, with improvements in diagnostic testing and establishment of international collaborative efforts to improve therapy. This article provides a framework to understand the impetus for increased screening as well as to identify key issues toward which collaborative efforts can be directed.

Keywords: Hepatitis delta; cirrhosis; interferon; pegylated interferon; prenylation inhibitors.

PubMed Disclaimer

References

    1. Rizzetto M. The delta agent. Hepatology. 1983;3(5):729–737. - PubMed
    1. Rizzetto M. Hepatitis D: thirty years after. J Hepatol. 2009;50(5):1043–1050. - PubMed
    1. Wedemeyer H, Yurdaydin C, Ernst S, et al. HIDIT-2 Study Group. Prolonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent HDV RNA relapse after treatment: the HIDIT-2 study. J Hepatol. 2014;60(1):S2–S3.
    1. Rizzetto M, Ponzetto A, Forzani I. Hepatitis delta virus as a global health problem. Vaccine. 1990;8(suppl):S10–S14. discussion S21-S23. - PubMed
    1. Rizzetto M, Alavian SM. Hepatitis delta: the rediscovery. Clin Liver Dis. 2013;17(3):475–487. - PubMed

LinkOut - more resources